支气管肺动脉成形术治疗支气管肺癌的体会

支气管肺动脉成形术治疗支气管肺癌的体会毛新高小增张胜卫侯波１９９０年５月至１９９６年６月，我科运用支气管成形或同时行肺动脉成形术对５例Ⅱ～Ⅲ期左上肺支气管肺癌的病人施行了手术治疗，扩大了手术适应症，疗效满意报告如下。临床资料本...     

支气管肺动脉成形术治疗中央型肺癌的体会

目的总结支气管肺动脉成形术治疗中央型肺癌的体会,探讨手术的技巧及防治并发症的方法。方法对入住本院胸外科的63例中央型肺癌患者施行支气管成形术或支气管肺动脉联合成形的临床资料进行总结并分析。结果全组病例均治愈出院,无发生吻合口狭窄及吻合口瘘等严重的并发症。结论支气管肺动脉成形术可使中央型肺癌患者免于全肺切除,达到最大限度保留健康的肺组织和肺功能,同时为后继的肿瘤综合治疗提供了足够的肺功能支持,提高了患者的生存时间和生存质量。     

支气管、肺动脉成形术治疗上叶中心型肺癌16例

我科于1994年1月至2005年10月，用支气管、肺动脉成形术治疗上叶中心型肺癌16例，扩大了手术适应证，避免了作全肺切除术，现报告如下。     

支气管肺动脉成形术治疗中央型肺癌的临床分析

目的探讨支气管肺动脉成形术治疗肺癌的效果。方法自2003年至2005年对36例肺癌患者施行支气管肺动脉同时成形术。术后病理诊断结果：鳞癌24例,腺癌6例,腺鳞癌5例,小细胞未分化癌1例。pTNM分期：ⅡB期5例（T2N1M0 4例,T3N0M0 1例）,ⅢA期27例（T3N1M0 11例,T2N2M0 9例,T3N2M0 7例）,ⅢB期4例（T4N0M0 1例,T4N1M0 1例,T4N2M0 2例）。结果该组手术近期死亡0例。术后1、3、5年生存率分别为74％（26／35）、48％（11／23）、33％（3／9）。结论采用支气管肺动脉同时成形术治疗中央型肺癌减少了全肺切除和单纯剖胸探查的率扩大了手术适应证,为肺癌患者提供了更有效、安全、合理的治疗机会。     

支气管肺动脉成形术在老年中央型肺癌中的疗效观察

目的探讨支气管肺动脉成形术在老年中央型肺癌中的疗效。方法 60例老年中央型肺癌患者,随机分为观察组和对照组,每组30例。对照组患者实施常规的中央型肺癌全肺切除术,观察组患者实施支气管肺动脉成形术,观察两组患者术后的生存时间,记录两组患者术后并发症的发生情况。结果观察组患者并发症（肺不张1例、吻合口狭窄或吻合口漏1例）发生率为6.7%;对照组患者并发症（肺部感染3例、呼吸衰竭3例、心血管并发症4例）发生率为33.3%;观察组并发症发生率低于对照组（P〈0.05）。观察组1年生存例数和3年生存例数分别为22例和13例,生存率分别为73.3%和43.3%;对照组患者1年生存例数和3年生存例数分别为21例和13例,生存率分别为70.0%和43.3%;观察组和对照组术后生存率比较,差异无统计学意义（P〉0.05）。结论支气管肺动脉成形术在老年中央型肺癌中的治疗效果显著,术后并发症少,值得借鉴。     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术治疗中央型肺癌的临床分析

Objective The aim of this study is to review the surgical experience of bronchoplasty and pulmo-nary arterioplasty in treatment of central-type lung cancer. Methods From 2003 to 2005,36 cases of patients with central-type lung cancer underwent bronchoplasty and pulmonary arterioplasty. There were 28 males and 8 females with a mean age of 62 years. Accordlng to pTNM classification. 5 cases were in stage ⅡI B,and 27 in stage Ⅲ A and 4 in stage Ⅲ B. Histologically,there were 24 cases of squamous cell carcinoma,6 cases of adenocarcinoma,1 case of small cell lung cancer and 5 cases of adenesquamous carcinoma. Results No patients died in the perioperative peri-od. The overall 1-,3-, and 5-year survival rate were 74% (26/35) ,48% (11/23) and 33% (3/9) ,respectively.Conclusion The results suggest that bronchoplasty and pulmonary arterioplasty can decrease the proportions of total pneumonectomy and exploratory thoracetomy and expand the indication of operation. Bronchoplasty and pulmonary ar-terioplasty can be achieved with satisfactory outcome for central-type lung cancer,especially for those patients with ad-vanced lesions or poor pulmonary function.     

支气管肺动脉成形术在老年人中央型肺癌治疗中的应用

目的：探讨对老年中央型肺癌患者采用支气管肺动脉成形术的疗效。方法78例老年中央型肺癌患者按照数字表法随机分为两组各39例,观察组采用支气管肺动脉成形术,对照组采用全肺切除术。比较两组患者1、3、5年生存率。统计术后并发症的发生率。测定术后3个月的肺功能变化。结果对照组术后1、3、5年生存率分别为66．7％（26/39）、46．2％（18/39）、30．8％（12/39）,观察组分别为79．5％（31/39）、56.4％（22/39）、38．5％（15/39）,两组差异均有统计学意义（χ^2=6．17、7．06、4．82,均P＜0．05）;对照组术后有11例（28．2％）发生并发症,观察组术后有4例（10．1％）发生并发症,两组差异有统计学意义（χ^2=6．32, P＜0．05）;两组治疗前FEV1、FVC、PEF差异均无统计学意义（t＝0．72、0．11、0．39,均P＞0．05）,治疗后两组FEV1、FVC、PEF均得到明显改善（t＝5．92、7．92、4．11、7．01、5．99、6．82,均P＜0．01）,且观察组改善程度明显优于对照组（t＝2．84、2．77、3．28,均P＜0．05）。结论支气管肺动脉成形术治疗老年中央型肺癌疗效显著,并发症少,可以进一步改善肺功能。     

肺动脉成形术在肺癌外科治疗中的应用

目前肺癌的治疗仍是以外科治疗为主的综合治疗 ,其中因肿瘤侵及肺动脉造成处理困难的较常见 ,我院自 1 996年 6月至 2 0 0 0年 1 2月在肺癌外科手术时共行肺动脉成形术 1 3例 ,现报告如下。临床资料一、一般资料1 3例中男 9例 ,女 4例 ;年龄 3 2～ 67岁 ,平均5 2岁。症状 :刺激性咳嗽 6例 ;胸痛 2例 ;咯血 4例 ;肺不张 2例。病变分期Ｔ1Ｎ1Ｍ0 4例 ;Ｔ1Ｎ2 Ｍ0 2例 ;Ｔ2 Ｎ1Ｍ0 6例 ;Ｔ2 Ｎ2 Ｍ0 1例。病变部位 :左上肺1 0例 ,右上肺 2例 ,右中下肺 1例。病理检查 :鳞癌1 1例 ,腺癌 2例。二、术中及术后情况手术方式 :左上肺切除及肺动脉成…     

支气管、肺动脉成形术治疗中央型肺癌的临床应用

目的总结支气管、肺动脉成形术治疗中央型肺癌的临床经验,探讨手术的应用指征及方法,以提高手术疗效和患者的生存率。方法回顾分析2001年5月至2006年5月我院35例中央型肺癌患者的手术治疗资料。支气管袖状切除左上叶10例、左下叶5例、右上肺12例、右中下叶8例,35例患者中,支气管及肺动脉双袖状切除11例,支气管袖式切除以及肺动脉侧壁切除3例。结果手术无死亡。手术后,发生并发症的患者有8例,占22.8%,其中,肺不张3例次,心律失常3例次,有肺不张、心律失常并且肺部发生感染2例,无支气管胸膜瘘和狭窄等严重并发症。术后1、3、5年的生存率分别为83%（29/35）、60%（21/35）和37%（13/35）。结论支气管、肺动脉成形术扩大了肺癌患者的手术指征,减少了因肺动脉受侵犯而行全肺切除术的概率,提高了患者术后的生存质量。     

支气管和肺动脉联合成形治疗中央型肺癌

目的总结支气管肺动脉成形术治疗中央型肺癌体会.方法 1995年9月～2003年1 2月,对12例中央型肺癌施行支气管肺动脉联合成形肺叶切除,包括双袖式左肺上叶切除6例;双袖式右肺上叶切除2例;双袖式右肺中上叶切除1例;双袖式右肺中上叶切除同时隆突重建1例;袖式左上肺叶切除、肺动脉楔形切除1例;袖式右肺中上叶切除、肺动脉楔形切除1例.结果本组无死亡及吻合口瘘发生.结论支气管肺动脉联合成形术使肺癌手术指征扩大,符合最大限度地切除肿瘤及最大限度保留肺功能的肺癌手术基本原则,是一种安全、有效、可行的术式.     

经支气管动脉灌注治疗肺癌

1978年Hellekant将9例肺鳞癌患者在手术前做支气管动脉内灌注丝裂霉素，经过28-48天后，手术及病理发现2例癌肿完全消失．1例几乎完全消失，2例部分消失，2例显著退化，而2例无变化，此方法对肺癌的治疗有肯定作用。刘子江在1990年报道支气管动脉灌注治疗抗癌药物治疗中，晚期肺癌227例疗效观察，其中CR（完全缓解）＋PR（部分缓解）占51．5％，CR＋PR＋S（稳定）占93．4％，P（进展）仅占6．6％，其疗效较为肯定。     

支气管成形肺切除术治疗支气管肺癌98例

我院胸外科从1988年12月～2002年11月施行支气管成形肺切除治疗支气管肺癌98例,治疗效果满意,报道如下:1 临床资料98例中男86例,女12例,年龄36～69岁,平均54.1岁。均为中央型肺癌,部位在右上叶42例,右中下叶19例,左上叶20例,左下叶17例。按国际TNM分期,Ⅰ期18例,Ⅱ期70例,Ⅲa期8例,Ⅲb期2例。98例术前均予支纤镜明确病理诊